MUTANT IDH-MEDIATED SUPPRESSION OF THE TH17 LINEAGE IN GLIOMA; BIOLOGIC IMPACT AND THERAPEUTIC POTENTIAL
Publication
, Conference
Reynolds, N; Soedel, A; Miller, E; Ashley, D; Waitkus, M; He, Y; Pirozzi, C
Published in: NEURO-ONCOLOGY
2023
Duke Scholars
Published In
NEURO-ONCOLOGY
EISSN
1523-5866
ISSN
1522-8517
Publication Date
2023
Volume
25
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Reynolds, N., Soedel, A., Miller, E., Ashley, D., Waitkus, M., He, Y., & Pirozzi, C. (2023). MUTANT IDH-MEDIATED SUPPRESSION OF THE TH17 LINEAGE IN GLIOMA; BIOLOGIC IMPACT AND THERAPEUTIC POTENTIAL. In NEURO-ONCOLOGY (Vol. 25).
Reynolds, Nathan, Ashleigh Soedel, Emily Miller, David Ashley, Matthew Waitkus, Yiping He, and Christopher Pirozzi. “MUTANT IDH-MEDIATED SUPPRESSION OF THE TH17 LINEAGE IN GLIOMA; BIOLOGIC IMPACT AND THERAPEUTIC POTENTIAL.” In NEURO-ONCOLOGY, Vol. 25, 2023.
Reynolds N, Soedel A, Miller E, Ashley D, Waitkus M, He Y, et al. MUTANT IDH-MEDIATED SUPPRESSION OF THE TH17 LINEAGE IN GLIOMA; BIOLOGIC IMPACT AND THERAPEUTIC POTENTIAL. In: NEURO-ONCOLOGY. 2023.
Reynolds, Nathan, et al. “MUTANT IDH-MEDIATED SUPPRESSION OF THE TH17 LINEAGE IN GLIOMA; BIOLOGIC IMPACT AND THERAPEUTIC POTENTIAL.” NEURO-ONCOLOGY, vol. 25, 2023.
Reynolds N, Soedel A, Miller E, Ashley D, Waitkus M, He Y, Pirozzi C. MUTANT IDH-MEDIATED SUPPRESSION OF THE TH17 LINEAGE IN GLIOMA; BIOLOGIC IMPACT AND THERAPEUTIC POTENTIAL. NEURO-ONCOLOGY. 2023.
Published In
NEURO-ONCOLOGY
EISSN
1523-5866
ISSN
1522-8517
Publication Date
2023
Volume
25
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences